CLINICAL_TRIALS
trial_result
· 2024-10-22
Clinical Trial Update: Open-label Study of Anakinra in MPS III [Phase 1, Phase 2]
Summary
An open-label Phase 1/2 trial evaluating Anakinra for Mucopolysaccharidosis type III has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lynda E Polgreen | Conditions: Mucopolysaccharidosis III | Phase 1, Phase 2 | Status: COMPLETED